510(k) Report

De Novo · Granted

Granted

MATRx plus

DEN170090De NovoGranted Aug 23, 2018245-day reviewClass II21 CFR 872.5571

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Zephyr Sleep Technologies · QCJ Closed Loop Auto Titration Device For Oral Appliances

Granted on Aug 23, 2018 as a new device type through De Novo after a 245-day review. 2 later devices descend from it.

Decided
Aug 23, 2018
Review
245 days
Class
Class II
Product code
QCJ
Recalls
None

2 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2019: 1 descendant cleared2020: 1 descendant cleared201620182020202220242026
  1. This deviceDEN170090 MATRx plusZephyr Sleep Technologies · 2018
  2. Descendant · cites it directly · 1 of its ownK191925 MATRx PlusZephyr Sleep Technologies · 2019
  3. Descendant · 2 generations on · 0 of its ownK200695 MATRx plusZephyr Sleep Technologies · 2020

Most influential descendants

Showing 2 of 2 · See all
  • K191925MATRx PlusZephyr Sleep Technologies · 2019 · cites it directly1descendant
  • K200695MATRx plusZephyr Sleep Technologies · 2020 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)DEN170090MATRx plusZephyr Sleep Technologies2018—
+1K191925MATRx PlusZephyr Sleep Technologies2019—
+2K200695MATRx plusZephyr Sleep Technologies2020—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201910
202010
FIG. 1 — Lineage of DEN170090, 2018–2020Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA De Novo database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QCJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

De Novo decisions do not claim a predicate device.

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K191925MATRx PlusZephyr Sleep Technologies20191

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K191925 (Zephyr Sleep Technologies, 2019) has gone furthest, with 1 descendant of its own.

How does its category compare?

All QCJ devices

QCJ Closed Loop Auto Titration Device For Oral Appliances: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · QCJ

1in 2018

2018: 1
2007high 1 (2018) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QCJ

Too few QCJ 510(k)s in any year since 2007 to give a median.

Recalls per year · QCJ

No recall names QCJ since 2007.

Adverse event reports per year · QCJ

No MAUDE report names QCJ since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20181—00
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

The MATRx plus device may also be used with an automated mandibular positioner that uses feedback control to record changes in the patient’s respiratory status related to repositioning of the mandible during an overnight study.

MATRx plus uses these recordings to produce a report for the HCP that can be used to prospectively identify patients with mild to moderate obstructive sleep apnea who may be suitable for therapy with an oral appliance and to recommend a target mandibular position.

The use of the device does not replace the need for follow-up testing to determine the initial and ongoing effectiveness of the therapy as recommended by clinical practice guidelines.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “DEN170090: MATRx plus.” Lineage record from FDA De Novo data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/DEN170090

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026